Browse > Article

Gene Expression of Metalloproteinases, Tissue Inhibitors of Metalloproteinases and Cytokines in Adriamycin-induced Cardiomyopathy  

Hong, Young Mi (Department of Pediatrics, College of Medicine, Ewha Womans University)
Publication Information
Clinical and Experimental Pediatrics / v.48, no.2, 2005 , pp. 197-203 More about this Journal
Abstract
Purpose : Changes in metalloproteinases(MMP) activity have been demonstrated in several disease states, including rheumatoid arthritis and tumor metastasis. More importantly, increased myocardial MMP activity has been reported to occur in both clinical and experimental forms of dilated cardiomyopathy. There was no report about MMP in adriamycin(ADR)-induced cardiomyopathy. The purpose of this study was to investigate gene expression of MMP and tissue inhibitor of metalloproteinases(TIMP) in ADR-induced cardiomyopathy and clarify the relationship between MMP and cytokines. Methods : Male Sprague-Dawley rats were divided into two groups. The first group was control. The second group was given intraperitoneal injections of ADR(5 mg/kg) twice a week over two weeks. Serum concentrations of MMP, TIMP, interleukin(IL)-6 and tumor necrosis factor(TNF)-${\alpha}$ were measured. RNA extraction was performed from frozen rat hearts. Reverse transcription polymerase chain reaction(RT-PCR) was employed. cDNA Microarray analysis was performed by using a set of 5,184 sequence-verified rat cDNA clones. Results : Serum MMP and TIMP levels were not significantly different between the two groups. IL-6 was $36.8{\pm}2.8pg/mL$ and TNF-${\alpha}$ $2.2{\pm}2.7pg/mL$ in the ADR group. They were significantly higher than in the control group. Serum MMP correlated significantly with TNF-${\alpha}$(r=0.41, P<0.05). There was no gene expression of MMP, IL-6 or TNF-${\alpha}$ in the hearts of both groups. Gene expression of TIMP was significantly depressed in the hearts of the ADR group. Conclusion : These results suggested a potential role for TNF-${\alpha}$ in the regulation of extracellular matrix remodeling in ADR induced cardiomyopathy. Rapid screening of multiple decreased gene expression by DNA chip may be a useful diagnostic test to detect early cardiac injury before developing ADR induced cardiomyopathy.
Keywords
Gene; Metalloproteinases; Cytokines; Adriamycin;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Thomas CV, Coker ML, Zellner JL, Handy JR, Crumbley AJ, Spinale FG. Increased matrix metalloproteinases activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy. Circulation 1998;97:1708-15   DOI   ScienceOn
2 Huber SA, Graveline D, Born WK, O'Brien RL. Cytokine production by V$gamma$(＋)-T-cell subsets is an important factor determing CD4＋-Th-cell phenotype and susceptability of BALB/c mice to coxsackievirus B3-induced myocarditis. J Virol 2001;75:5860-9.   DOI   ScienceOn
3 Torre-Amione G, Kapadia S, Lee J, Bies RD, Lebovitz R, Mann DL. Expression and functional significance of tumor necrosis factor receptors in human myocardium. Circulation 1995;92:1487-93   DOI   ScienceOn
4 Petretta M, Condorelli GL, Spinelli L, Scopacasa F, De Caterina M, Leosco D, et al. Circulating levels of cytokines and their site of production in patients with mild to severe chronic heart failure. Am Heart J 2000;144:e28
5 Torre-Amione G, Kapadia S, Lee J, Durand JB, Bies RD, Young JB, et al. Tumor necrosis factor-$alpha$ and tumor necrosis factor receptors in the failing human heart. Circulation 1996;93:704-11   DOI   ScienceOn
6 Kapadia S, Oral H, Lee J, Nakano M, Taffet GE, Mann DL. Hemodynamic regulation of tumor necrosis factor-alpha gene and protein expression in adult feline myocardium. Circ Res 1997;81:187-95   DOI   ScienceOn
7 Niebauer J, Volk HD, Kemp M, Dominguez M, Schmann RR, Rauchhaus M, et al. Endotoxin and immune activation in chronic heart failure : a prospective cohort study. Lancet 1999;353:1838-42   DOI   ScienceOn
8 Hasper D, Hummel M, Klebel FX, Reindl I, Volk HD. Systemic inflammation in patients with heart failure. Eur Heart J 1998;19:761-5   DOI   ScienceOn
9 Anker SD, Chua TP, Ponikowski P, Harrington D, Swan JW, Kox WJ, et al. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation 1997;96:526-34   DOI   ScienceOn
10 Pattern-Hitt E. Gene chips and cancer diagnosis. Nature Med 2001;7:673-79.   DOI   ScienceOn
11 Habib FM, Springall DR, Davies GJ, Oakley CM, Yacoub MH, Polak JM. Tumor necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy. Lancet 1996;347: 1151-5   DOI   ScienceOn
12 Blankenberg S, Rupprecht HJ, Poirier O, Bickel C, Smieja K, Hafner G, et al. Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular diasease. Circulation 2003;107: 1579-85   DOI   ScienceOn
13 Wada H, Saito K, Kanda T, Kobayashi I, Fujii H, Fujigaki S, et al. Tumor necrosis factor $alpha$(TNF-$alpha$) plays a protective role in acute viral myocarditis in mice. A study using mice lacking TNF-$alpha$. Circulation 2001;103:743-9   DOI   ScienceOn
14 Henke A, Mohr C, Sprenger H, Graebner C, Stelzner A, Nain M, et al. Coxsackievirus B3-induced production of tumor necrosis factor-$alpha$, IL-1$beta$, and IL-6 in human monocytes. J Immunol 1992;148:2270-7
15 Hong YM, Lim BK, Shin JO, Jeon ES. Change of serum cardiac troponin T and fetal troponin T isoform in rats with adriamycin-induced cardiac injury. Korean Cir J 2002; 32:485-91   DOI
16 Roig E, Orus J, Pare C, Azqueta M, Filella X, Perez-Villa F, et al. Serum interleukin-6 in congestive heart failure secondary to idiopathic dilated cardiomyopathy. Am J Cardiol 1998;82:688-90   DOI   PUBMED   ScienceOn
17 Eddy LJ, Goeddel DV, Wong GH. Tumor necrosis factor- $alpha$ pretreatment is protective in rat model of myocardial ischemia- perfusion injury. Biochem Biophys Res Comm 1992; 184:1056-9   DOI   ScienceOn
18 Yamaguchi-Takihara K, Ihara Y, Ogata A, Yoshizaki K, Azuma J, Kishimoto Y. Hypoxic stress induces cardiac myocyte-derived interleukin-6. Circulation 1995;91:1520-4   DOI   ScienceOn
19 Mann DL. Stress activated cytokines and the heart. Cytokine Growth Factor Rev 1996;7:341-54   DOI   PUBMED   ScienceOn
20 Tyagi SC, Campbell SE, Reddy HK, Tjahja E, Voelker DJ. Matrix metalloproteinase activity expression in infarcted, noninfarcted and dilated cardiomyopathic human hearts. Mol Cell Biochem 1996;155:13-21   DOI   ScienceOn
21 Sharma R, Coats AJ, Anker MD. The role of inflammatory mediators in chronic heart failure : cytokines, nitric oxide, and endothelin-1. Int J Cardiol 2000;72:175-86   DOI   ScienceOn
22 Satoh M, Tamura G, Segawa I, Tashiro A, Hiramori K, Satodate R. Expression of cytokine genes and presence of enteroviral genomic RNA in endomyocardial biopsy tissues of myocarditis and dilated cardiomyopathy. Virchows Arch 1996;427:503-9
23 Buzadar AV, Marcus CS, Smith TL, Blumenschein GR. Early and delayed clinical cardiotoxicity of doxorubicin. Cancer 1985;55;2761-5   DOI   PUBMED   ScienceOn
24 Dollery CM, McEwan JR, Henney AM. Matrix metalloproteinases and cardiovascular disease. Cir Res 1995;77:863-8   DOI   ScienceOn
25 Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Ele-vated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990;323:236-41   DOI   ScienceOn
26 Tsutamoto T, Hisanaga T, Wada A, Maeda K, Ohnishi M, Fukai D, et al. Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure. J Am Coll Cardiol 1998;31:391-8
27 Munger MA, Johnson B, Amber IJ, Callahan KS, Gibert EM. Circulating concentrations of proinflammatory cytokines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1996;77:723-7   DOI   PUBMED   ScienceOn
28 Siwik DA, Chang DL, Colucci WS. Interluekin-1 $beta$ and tumor necrosis factor-$alpha$ decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblast in vitro. Cir Res 2000;86:1259-65   DOI   ScienceOn
29 Munger MA, Johnson B, Amber IJ, Callahan KS, Gibert EM. Circulating concentrations of proinflammatory cytokines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1996;77:723-7   DOI   PUBMED   ScienceOn
30 Levine J, Kalman L, Mayer H, Fillit H, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990;323:236-41   DOI   ScienceOn
31 Munkvad S, Gram J, Jespersen J. Interleukin-1 and tumor necrosis factor-alpha in plasma of patients with acute ischemic heart disease who undergo thrombolytic therapy : a randomized, placebo-controlled study. Lymphokine Cytokine Res 1991;10:325-7
32 MacNaul KL, Chartrain N, Lark M, Tocci MJ, Hutchinson NI. Discordinate expression of stromelysin, collagenase, and tissue inhibitor of metalloprotinase-1 in rheumatoid human synovial fibroblast : synergistic effects of interleukin-1 and tumor necrosis factor-$alpha$ on stromelysin expression. J Biol Chem 1990;265:17238-45
33 Spinale FG, Coker ML, Heung LJ, Bond BR, Gunasinghe HR, Etoh T, et al. A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure. Circulation 2000;102:1944-9   DOI   ScienceOn
34 Mariadason JM, Augenlicht LH, Arango D. Microarray analysis in the clinical management of cancer. Hematol Oncol Clin North Am 2003;17:377-87   DOI   ScienceOn
35 Gunja-Smith Z, Morales AR, Romanelli R, Woessner JF. Remodeling of human myocardial collagen in idiopathic dilated cardiomyopathy : role of metalloproteinases and pyridinoline cross links. Am J Pathol 1996;148:1639-48
36 Weber KT, Pick R, Janicki JS, Gadodia G, Lakier JB. Inadequate collagen tethers in dilated cardiomyopathy. Am Heart J 1988;116:1641-6   DOI   ScienceOn
37 Mann DL. Tumor necrosis factor and viral myocarditis : The fine line between innate and inappropriate immune responses in the heart. Circulation 2001;103;626-9   DOI   ScienceOn
38 Hong YM, Kim SS. The role of apoptosis in adriamycin induced cardiotoxicity and preventive effect of L-carnitine in rat. Korean J Pediatr 1998;41:760-8
39 Kantrowitz ME, Bristow MR. Cardiotoxicity of antitumor agents. Prog Cardiovasc Dis 1984;27:195-200   DOI   ScienceOn